Neutrophil Gelatinase–Associated Lipocalin and Contrast-Induced Acute Kidney Injury
Authors:
- Cristina QuintavalleCQCristina Quintavalle
- Chiara Viviani AnselmiCAChiara Viviani Anselmi
- Francesca De MiccoFMFrancesca De Micco
- Giuseppina RoscignoGRGiuseppina Roscigno
- Gabriella ViscontiGVGabriella Visconti
- Bruno GoliaBGBruno Golia
- Amelia FocaccioAFAmelia Focaccio
- Bruno RicciardelliBRBruno Ricciardelli
- Enzo PernaEPEnzo Perna
- Laura PapaLPLaura Papa
- Elvira DonnarummaEDElvira Donnarumma
- Gerolama CondorelliGerolama Condorelli
- 1 September 2015
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 8 (9) , e002673
Abstract
Background—: Neutrophil gelatinase–associated lipocalin (NGAL) is an early marker of acute kidney injury (AKI). Methods and Results—: Urine NGAL and serum NGAL (sNGAL) were assessed at 2, 6, 24, and 48 hours after contrast media (CM) exposure in 458 high-risk patients (development set). Optimal thresholds in predicting contrast-induced AKI (serum creatinine [sCr] increase ≥0.3 mg/dL at 48 hours after CM administration) were identified. Major adverse events (MAE; death, dialysis, nonfatal myocardial infarction, sustained kidney injury, and myocardial revascularization) at 1 year were assessed. In the development set, optimal thresholds for contrast-induced AKI occurred at 6 hours for both urine NGAL (≥20 ng/mL; 97% negative predictive value and 27% positive predictive value) and sNGAL (≥179 ng/mL; 93% negative predictive value and 20% positive predictive value). Furthermore, sNGAL ≥179 ng/mL at 6 hours was an independent predictor of 1-year MAE. 1-year MAE occurred in 27/198 patients (13.5%) with sNGAL <179 ng/mL and sCr <0.3 mg/dL, in 57/193 (29.5%) patients with only sNGAL ≥179 ng/mL, and in 37/67 (55%) patients with sCr ≥0.3 mg/dL. In additional 253 patients (validation set), no patient with urine NGAL <20 ng/mL or sNGAL <179 ng/mL at 6 hours developed contrast-induced AKI. Furthermore, 6/68 (9%) patients with sNGAL <179 ng/mL and sCr increase <0.3 mg/dL had 1-year MAE versus 17/57 (30%) patients with sNGAL ≥179 ng/mL and sCr increase <0.3 mg/dL and 8/16 (50%) patients with sCr increase ≥0.3 mg/dL. Conclusions—: Urine NGAL <20 ng/mL and sNGAL <179 ng/mL at 6 hours are reliable markers for ruling out contrast-induced AKI. sNGAL ≥179 ng/mL at 6 hours predicts 1-year MAE. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01098032.Keywords
This publication has 29 references indexed in Scilit:
- Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conferenceKidney International, 2014
- Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron DamageJACC, 2012
- Defining the length of stay following percutaneous coronary interventionCatheterization and Cardiovascular Interventions, 2009
- Urinary Neutrophil Gelatinase-Associated Lipocalin and Acute Kidney Injury After Cardiac SurgeryAmerican Journal of Kidney Diseases, 2008
- Contrast-Induced Acute Kidney InjuryJACC, 2008
- Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort studyCritical Care, 2007
- Neutrophil-Gelatinase-Associated Lipocalin and Renal Function after Percutaneous Coronary InterventionsAmerican Journal of Nephrology, 2006
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgeryThe Lancet, 2005
- Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal InjuryJournal of the American Society of Nephrology, 2003
- Molecular Characterization and Pattern of Tissue Expression of the Gene for Neutrophil Gelatinase-Associated Lipocalin from HumansGenomics, 1997